Business Description
UroGen Pharma is a New Jersey-based company focused on developing and bringing to market new treatments for bladder and urinary tract cancers. Its core technology is a gel-based drug delivery system that allows medications to remain in contact with affected tissue longer than traditional methods, improving treatment effectiveness. The company has two approved products on the market and several others in clinical trials at various stages of development. UroGen works with partners including Agenus and medac to expand its product pipeline and reach more patients.
